IL122813A0 - Thrombin inhibitors their preparation and use - Google Patents
Thrombin inhibitors their preparation and useInfo
- Publication number
- IL122813A0 IL122813A0 IL12281396A IL12281396A IL122813A0 IL 122813 A0 IL122813 A0 IL 122813A0 IL 12281396 A IL12281396 A IL 12281396A IL 12281396 A IL12281396 A IL 12281396A IL 122813 A0 IL122813 A0 IL 122813A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- thrombin inhibitors
- thrombin
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9502487A SE9502487D0 (sv) | 1995-07-06 | 1995-07-06 | New amino acid derivatives |
| SE9502504A SE9502504D0 (sv) | 1995-07-07 | 1995-07-07 | New amino acid derivatives |
| SE9502505A SE9502505D0 (sv) | 1995-07-07 | 1995-07-07 | New amino acid derivatives |
| SE9503923A SE9503923D0 (sv) | 1995-11-07 | 1995-11-07 | New amino acid derivatives |
| SE9504349A SE9504349D0 (sv) | 1995-12-05 | 1995-12-05 | New amino acid derivatives |
| GBGB9526411.5A GB9526411D0 (en) | 1995-12-22 | 1995-12-22 | Compounds |
| PCT/SE1996/000878 WO1997002284A1 (en) | 1995-07-06 | 1996-07-02 | New thrombin inhibitors, their preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL122813A0 true IL122813A0 (en) | 1998-08-16 |
Family
ID=27547251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12281396A IL122813A0 (en) | 1995-07-06 | 1996-07-02 | Thrombin inhibitors their preparation and use |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US6051568A (da) |
| EP (1) | EP0836615B1 (da) |
| JP (1) | JP4107682B2 (da) |
| KR (1) | KR100435008B1 (da) |
| CN (1) | CN1147504C (da) |
| AR (1) | AR003440A1 (da) |
| AT (1) | ATE238342T1 (da) |
| AU (1) | AU709710B2 (da) |
| BR (1) | BR9609447A (da) |
| CA (1) | CA2226256C (da) |
| CZ (1) | CZ298487B6 (da) |
| DE (1) | DE69627659T2 (da) |
| DK (1) | DK0836615T3 (da) |
| EE (1) | EE04500B1 (da) |
| ES (1) | ES2197240T3 (da) |
| HK (1) | HK1008995A1 (da) |
| HU (1) | HUP9802315A3 (da) |
| IL (1) | IL122813A0 (da) |
| IS (1) | IS2081B (da) |
| MX (1) | MX9800146A (da) |
| MY (1) | MY116539A (da) |
| NO (1) | NO324092B1 (da) |
| NZ (2) | NZ311854A (da) |
| PL (1) | PL185606B1 (da) |
| PT (1) | PT836615E (da) |
| RU (1) | RU2176645C2 (da) |
| SA (1) | SA96170106A (da) |
| SI (1) | SI0836615T1 (da) |
| SK (1) | SK284695B6 (da) |
| TR (1) | TR199800009T1 (da) |
| WO (1) | WO1997002284A1 (da) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SA96170106A (ar) * | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
| SE9602263D0 (sv) | 1996-06-07 | 1996-06-07 | Astra Ab | New amino acid derivatives |
| WO1997049404A1 (en) | 1996-06-25 | 1997-12-31 | Eli Lilly And Company | Anticoagulant agents |
| US6200967B1 (en) | 1996-06-25 | 2001-03-13 | Eli Lilly And Company | Anticoagulant agents |
| SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
| AR013084A1 (es) | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
| SE9704543D0 (sv) * | 1997-12-05 | 1997-12-05 | Astra Ab | New compounds |
| AU750561B2 (en) | 1998-04-24 | 2002-07-25 | 3-Dimensional Pharmaceuticals, Inc. | Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
| SE9802938D0 (sv) | 1998-09-01 | 1998-09-01 | Astra Ab | Improved stability for injection solutions |
| AU1185400A (en) * | 1998-11-20 | 2000-06-13 | Banyu Pharmaceutical Co., Ltd. | 1-acylazetidine derivatives |
| SE9804313D0 (sv) | 1998-12-14 | 1998-12-14 | Astra Ab | New compounds |
| CA2355792A1 (en) * | 1999-01-13 | 2000-07-20 | Astrazeneca Ab | New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
| SE0001803D0 (sv) | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
| US6433186B1 (en) * | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
| EP1311480B1 (en) * | 2000-08-16 | 2008-09-03 | AstraZeneca AB | New amidino derivatives and their use as thrombin inhibitors |
| AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
| US7129233B2 (en) | 2000-12-01 | 2006-10-31 | Astrazeneca Ab | Mandelic acid derivatives and their use as thrombin inhibitors |
| SE0102921D0 (sv) * | 2001-08-30 | 2001-08-30 | Astrazeneca Ab | Pharmaceutically useful compounds |
| US6528503B2 (en) * | 2000-12-18 | 2003-03-04 | Merck & Co., Inc. | Thrombin inhibitors |
| US7144899B2 (en) * | 2001-02-09 | 2006-12-05 | Merck & Co., Inc. | Thrombin inhibitors |
| SE0101762D0 (sv) * | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | New use |
| AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
| UA78195C2 (uk) * | 2001-08-30 | 2007-03-15 | Astrazeneca Ab | Похідні мигдалевої кислоти та їх застосування як інгібіторів тромбіну, фармацевтична композиція на їх основі |
| SE0201658D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Immediate release pharmaceutical formulation |
| SE0201659D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
| SE0201661D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
| US7781424B2 (en) * | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
| US7524354B2 (en) * | 2005-07-07 | 2009-04-28 | Research Foundation Of State University Of New York | Controlled synthesis of highly monodispersed gold nanoparticles |
| TW200827336A (en) | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
| US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU178398B (en) * | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
| HU192646B (en) * | 1984-12-21 | 1987-06-29 | Gyogyszerkutato Intezet | Process for preparing new n-alkyl-peptide aldehydes |
| AU600226B2 (en) * | 1985-02-04 | 1990-08-09 | Merrell Pharmaceuticals Inc. | Novel peptidase inhibitors |
| US5187157A (en) * | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
| EP0362002B1 (en) * | 1988-09-01 | 1995-07-26 | Merrell Dow Pharmaceuticals Inc. | HIV protease inhibitors |
| ZA897514B (en) * | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
| TW201303B (da) * | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
| CA2075154A1 (en) * | 1991-08-06 | 1993-02-07 | Neelakantan Balasubramanian | Peptide aldehydes as antithrombotic agents |
| SE9102462D0 (sv) * | 1991-08-28 | 1991-08-28 | Astra Ab | New isosteric peptides |
| CZ333492A3 (en) * | 1991-11-12 | 1993-09-15 | Lilly Co Eli | Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised |
| SE9103612D0 (sv) * | 1991-12-04 | 1991-12-04 | Astra Ab | New peptide derivatives |
| CA2131367A1 (en) * | 1992-03-04 | 1993-09-16 | Sandor Bajusz | New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof |
| TW223629B (da) | 1992-03-06 | 1994-05-11 | Hoffmann La Roche | |
| US5519193A (en) | 1992-10-27 | 1996-05-21 | International Business Machines Corporation | Method and apparatus for stressing, burning in and reducing leakage current of electronic devices using microwave radiation |
| AU675981B2 (en) * | 1992-12-02 | 1997-02-27 | Bristol-Myers Squibb Company | Guanidinyl-substituted heterocyclic thrombin inhibitors |
| US5583146A (en) * | 1992-12-02 | 1996-12-10 | Bristol-Myers Squibb Company | Heterocyclic thrombin inhibitors |
| US5780631A (en) * | 1993-06-03 | 1998-07-14 | Astra Aktiebolag | Starting materials in the synthesis of thrombin and kininogenase inhibitors |
| SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
| DE4321444A1 (de) * | 1993-06-28 | 1995-01-05 | Bernd Prof Dr Clement | Pharmazeutische Zubereitung |
| EP0648780A1 (en) * | 1993-08-26 | 1995-04-19 | Bristol-Myers Squibb Company | Heterocyclic thrombin inhibitors |
| TW394760B (en) * | 1993-09-07 | 2000-06-21 | Hoffmann La Roche | Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same |
| AU1025795A (en) * | 1994-01-27 | 1995-08-03 | Mitsubishi Chemical Corporation | Prolineamide derivatives |
| ZA951617B (en) * | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
| US5707966A (en) * | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
| US5726159A (en) * | 1994-03-04 | 1998-03-10 | Eli Lilly And Company | Antithrombotic agents |
| US5705487A (en) * | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
| US5561146A (en) * | 1994-06-10 | 1996-10-01 | Bristol-Myers Squibb Company | Modified guanidino and amidino thrombin inhibitors |
| DE4421052A1 (de) * | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
| US5510369A (en) * | 1994-07-22 | 1996-04-23 | Merck & Co., Inc. | Pyrrolidine thrombin inhibitors |
| MX9703839A (es) * | 1994-11-24 | 1997-08-30 | Janssen Pharmaceutica Nv | Soluciones intravenosas de lubeluzol. |
| MX9706069A (es) * | 1995-02-17 | 1997-10-31 | Basf Ag | Nuevos inhibidores de la trombina. |
| US5710130A (en) * | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
| US5629324A (en) | 1995-04-10 | 1997-05-13 | Merck & Co., Inc. | Thrombin inhibitors |
| SA96170106A (ar) * | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
| SE9602263D0 (sv) * | 1996-06-07 | 1996-06-07 | Astra Ab | New amino acid derivatives |
-
1996
- 1996-06-22 SA SA96170106A patent/SA96170106A/ar unknown
- 1996-06-24 AR ARP960103292A patent/AR003440A1/es active IP Right Grant
- 1996-07-02 TR TR1998/00009T patent/TR199800009T1/xx unknown
- 1996-07-02 CN CNB961967811A patent/CN1147504C/zh not_active Expired - Fee Related
- 1996-07-02 DE DE69627659T patent/DE69627659T2/de not_active Expired - Fee Related
- 1996-07-02 AT AT96922355T patent/ATE238342T1/de not_active IP Right Cessation
- 1996-07-02 PT PT96922355T patent/PT836615E/pt unknown
- 1996-07-02 CA CA002226256A patent/CA2226256C/en not_active Expired - Fee Related
- 1996-07-02 ES ES96922355T patent/ES2197240T3/es not_active Expired - Lifetime
- 1996-07-02 SI SI9630615T patent/SI0836615T1/xx unknown
- 1996-07-02 HU HU9802315A patent/HUP9802315A3/hu unknown
- 1996-07-02 EE EE9700354A patent/EE04500B1/xx not_active IP Right Cessation
- 1996-07-02 EP EP96922355A patent/EP0836615B1/en not_active Expired - Lifetime
- 1996-07-02 AU AU63253/96A patent/AU709710B2/en not_active Ceased
- 1996-07-02 BR BR9609447A patent/BR9609447A/pt not_active Application Discontinuation
- 1996-07-02 DK DK96922355T patent/DK0836615T3/da active
- 1996-07-02 SK SK1804-97A patent/SK284695B6/sk not_active IP Right Cessation
- 1996-07-02 NZ NZ311854A patent/NZ311854A/en not_active IP Right Cessation
- 1996-07-02 RU RU98102188/04A patent/RU2176645C2/ru not_active IP Right Cessation
- 1996-07-02 KR KR10-1998-0700054A patent/KR100435008B1/ko not_active IP Right Cessation
- 1996-07-02 WO PCT/SE1996/000878 patent/WO1997002284A1/en active IP Right Grant
- 1996-07-02 MX MX9800146A patent/MX9800146A/es active IP Right Grant
- 1996-07-02 NZ NZ509474A patent/NZ509474A/en not_active IP Right Cessation
- 1996-07-02 US US08/687,466 patent/US6051568A/en not_active Expired - Fee Related
- 1996-07-02 JP JP50507197A patent/JP4107682B2/ja not_active Expired - Fee Related
- 1996-07-02 IL IL12281396A patent/IL122813A0/xx unknown
- 1996-07-02 CZ CZ0421297A patent/CZ298487B6/cs not_active IP Right Cessation
- 1996-07-02 PL PL96324483A patent/PL185606B1/pl not_active IP Right Cessation
- 1996-07-05 MY MYPI96002787A patent/MY116539A/en unknown
-
1997
- 1997-12-22 IS IS4639A patent/IS2081B/is unknown
-
1998
- 1998-01-02 NO NO19980015A patent/NO324092B1/no not_active IP Right Cessation
- 1998-08-07 HK HK98109754A patent/HK1008995A1/xx not_active IP Right Cessation
-
2000
- 2000-03-29 US US09/537,344 patent/US6337343B1/en not_active Expired - Fee Related
-
2001
- 2001-11-29 US US09/995,564 patent/US6617320B2/en not_active Expired - Fee Related
-
2003
- 2003-06-26 US US10/606,349 patent/US6921758B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL122813A0 (en) | Thrombin inhibitors their preparation and use | |
| GB2298422B (en) | Compounds and their use | |
| EP0820453A4 (en) | THROMBIN INHIBITORS | |
| HRP960075B1 (en) | New thrombin inhibitors | |
| HRP970680B1 (en) | New ketobenzamides and their use | |
| IL118825A0 (en) | 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use | |
| IL119864A0 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use | |
| SG44943A1 (en) | Metallocene preparation and use | |
| IL116851A0 (en) | 3-arylidene-2-oxindole derivatives their preparation and use | |
| IL127885A0 (en) | Amidino derivatives and their use as thrombin inhibitors | |
| IL120124A0 (en) | Heteroaryl-oxazolidinones their preparation and use | |
| HUP0104500A3 (en) | Thrombin inhibitor dipeptide derivatives and their use | |
| IL119466A0 (en) | Thrombin inhibitors their preparation and pharmaceutical compositions containing them | |
| IL118442A0 (en) | Triazolymethyl-cyclopentanols their preparation and use | |
| IL122216A0 (en) | Dolastatin derivatives their preparation and use | |
| IL133490A0 (en) | New amidino derivatives and their use as thrombin inhibitors | |
| GB9525812D0 (en) | Composition and use | |
| IL118441A0 (en) | Triazolymethyl-oxiranes their preparation and use | |
| EP0836617A4 (en) | PAREVINES AND TACHYTEGRINES | |
| IL118443A0 (en) | Cycloalkane-benzylidene derivatives their preparation and use | |
| IL117437A0 (en) | Novel thrombin inhibitors | |
| AU3634595A (en) | Bis-oxazolidines and their use | |
| HUP9800146A3 (en) | Thalidomide-derivatives and use of them | |
| EP0744125A3 (en) | Iodine complex and its application | |
| EP0835123A4 (en) | AMINOPEPTIDASE P INHIBITORS AND USES THEREOF |